Resize text 
Resize text 
WHAT IS THIS REPORT?
This report is the result of reviewing, compiling and updating knowledge about European sources of data on drug utilisation in the out- and inpatient health care sector. Information is available on Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Spain, Sweden and United Kingdom.
It is a work in progress: further European countries will be included and the report is regularly updated.
GOALS OF THE DOCUMENT
It describes the characteristics of non-commercial drug consumption data providers in Europe, with special emphasis on pricing and reimbursement agencies. It reports the features of each country health policy systems and lists several pharmaceutical data sources. It includes a brief summary of data provided by Intercontinental Marketing Services (IMS Health).
It provides an updated list of national drug consumption databases in selected European countries, describing their main characteristics and accessibility.
It outlines the validity of these European national drug consumption databases.
It explores the availability of inpatient drug consumption data at national level.
WHO MAY BE INTERESTED IN IT?
This inventory is a shared resource for all researchers interested in pharmacoepidemiology and drug utilisation research in particular. Having this in mind, we encourage institutions and individuals within and outside the PROTECT project to critically review this report and make recommendations on change.
For queries, please contact Dr Luisa Ibáñez (li@icf.uab.cat) or Dr Hans Petri (hans.petri@roche.com)
Links: >> Inventory on Drug Utilisation - Master Document (version August 2011) |
